Endocare Reports Financial Results for Third Quarter 2008.
Net Revenues Rise, Net Loss Narrows Compared to Prior Year; Operating Loss Declines 26% IRVINE, Calif., Nov. 10 /PRNewswire-FirstCall/ -- Endocare, Inc. , an innovative medical device company focused on the development of minimally invasive technologies used by urologists and interventional radiologists for tissue and tumor ablation,...

Interim Analysis of Top-Line Data From Phase II/III Study Shows Favorable Efficacy & Safety for Corthera's Relaxin in Acute Heart Failure.
SAN MATEOEoACAU Calif.EoACAU Nov. 10 /PRNewswire/ -- Corthera Inc. today announced that an interim analysis of top-line data from Pre-RELAX-AHF, the Phase II portion of a Phase II/III multicenter, randomized, double-blind, international study, showed favorable efficacy and safety for relaxin, the company's investigational drug for treatment of acute heart...

OBITUARIES.
Byline: The Register-Guard Melvin Bruner OAKRIDGE - A memorial service will be held at 2 p.m. Nov. 1 at the Oakridge Moose Lodge for Melvin "Red" Bruner of Oakridge, who died Oct. 21 of dementia. He was 79. He was born April 30,...

Farewell Wellington women's clinic.
The Wellington Graduate Nurses Association was formed in July 1971 to bring together Graduate Nurses for fellowship and ongoing education. In early 1978, the Wellington Country Women's Association asked if the Association would run a clinic around female health issues, as there were no female doctors in...

Coffee myths busted.
Caffeine addicts can raise their cups and take heart from the latest studies into the health effects of drinking coffee--well, at least until the next round of contradictory research, that is. The New York Times recently compiled these findings so crank up the espresso machine, pour yourself a long,...

Unique New Initiative by World-Recognized Specialists in Heart Disease and Diabetes to Reduce Residual Vascular Risk Launched Today.
NEW ORLEANS and LOS ANGELES, November 10 /PRNewswire/ -- - Current Treatment Fails to Abolish Majority of Vascular Risk - Residual Risk Reduction Initiative (R3i) Calls for Action to Reduce the Lipid-Related Residual Vascular Risk Unaddressed by Current Standards of Care in Millions of Patients With Heart...

Tour DaVita Raises More Than $400K for Kidney Disease Awareness.
2nd annual bike ride drives home importance of awareness and education of kidney disease EL SEGUNDO, Calif., Nov. 10 /PRNewswire/ -- In an effort to raise money for The Kidney TRUST(TM) -- a non-profit organization aimed at prevention and awareness of chronic kidney disease (CKD) -- DaVita...

China Sky One Medical, Inc. Announces Record Third Quarter 2008 Results.
HARBIN, China, Nov. 10 /Xinhua-PRNewswire-FirstCall/ -- China Sky One Medical, Inc. ("China Sky One Medical" or "the Company") , a leading fully integrated pharmaceutical company producing over-the-counter drugs in the People's Republic of China ("PRC"), today announced record financial results for the third quarter ended September 30, 2008. ...

Allos Therapeutics Releases 2008 Third Quarter Results.
HEALTH AND BEAUTY CLOSE-UP-11 November 2008-Allos Therapeutics Releases 2008 Third Quarter Results(C)2008 - CloseUpMedia - newsdesk@closeupmedia.com Allos Therapeutics today reported results for the third quarter of 2008. In a release, the Company noted that for the three months ended September 30, the Company reported a...

3SBio Inc. Files for SFDA Approval of NuLeusin.
SHENYANG, China, Nov. 10 /Xinhua-PRNewswire/ -- 3SBio Inc. , a leading biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China, today announced that it has filed with the Chinese State Food and Drug Administration (SFDA) for approval of NuLeusin for the treatment of late...